In-stent Restenosis Common in PCI
In-stent restenosis (ISR) represents approximately 10% of all PCIs in the United States and is...
Breaking Cardiology
SGLT2 Inhibitors Improve Measures of Heart Function
Empagliflozin trial tracks ways SGLT2i treatment may slow adverse remodeling in heart The past 18...
Lipid-Lowering Treatment Shows Benefit In Patients over 70
Underrepresented population examined in two studies Lipid-lowering treatments, including but not...
